To assess the ability of the DltA inhibitor to improve G. mellonella survival in a MRSE infection model, larvae were infected with lethal doses of strains MRSE 11 (Fig. 5A) or MRSE 20 (Fig. 5B) and treated by injection of saline solution, IPM (0.6 mg/kg), DltA inhibitor (48.5 mg/kg) or IPM/DltA inhibitor combination at the same concentrations 2 h post-infection. The gene discussed is DLAT; the disease is infection.